Public trial registry of the CCC-Munich

Trial FIRE-6 Avelumab Study

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
FIRE-6 Avelumab Study
World
Full title
:

Avelumab Added to FOLFIRI plus Cetuximab Followed by Avelumab Maintenance in Patients with Previously Untreated RAS/BRAF Wild-Type Metastatic Colorectal Cancer

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Colorectal carcinoma
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo,Zielgerichtet - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Sylvie Lorenzen 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier